Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.87B | $1.87B | -0.31% |
Gross Profit | $1.11B | $1.11B | -0.72% |
Net Income | $202.35M | $221.81M | -8.78% |
EPS (Basic) | $17.61 | $18.70 | -5.83% |
EPS (Diluted) | $17.56 | $18.60 | -5.59% |
R&D Expense | $95.63M | $92.19M | +3.74% |
SG&A Expense | $490.1M | $470.19M | +4.23% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.4B | $3.25B | +4.66% |
Current Assets | $1.24B | $1.18B | +5.61% |
Total Liabilities | $3.66B | $3.4B | +7.56% |
Current Liabilities | $1.11B | $1.28B | -13.60% |
Stockholders' Equity | $-258.79M | $-152.76M | -69.41% |
Cash & Equivalents | $61.83M | $70.81M | -12.69% |
Long-Term Debt | $2.12B | $1.75B | +21.59% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $430.81M | $447.49M | -3.73% |
Investing Cash Flow | $-54.56M | $-30.77M | -77.32% |
Financing Cash Flow | $-370.15M | $-413.39M | +10.46% |
Share Buybacks | $437.5M | $425M | +2.94% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 59.2% | 59.5% | -0.25% |
Net Margin | 10.8% | — | — |
ROE | -78.2% | — | — |
ROA | 6.0% | — | — |
Current Ratio | $1.124 | — | — |
Debt to Equity | $-14.14 | — | — |
Other companies in Life Sciences Tools & Services